(Reuters) - South Africa's food and pharmaceuticals group Tiger Brands said on Friday it would divest its drug and hospital interests, sending its shares surging.
Tiger Brands, South Africa's biggest consumer-branded products group, said in a statement it had appointed investment bank UBS South Africa to evaluate options, including a potential sale or unbundling and separate listing of the interests.
Read more at Reuters Africa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment